Practicalities of setting up a phase I clinical trial unit within an academic center

David S. Hong; Kathrina L. Marcelo-Lewis; Patricia LoRusso

doi:10.1007/978-3-030-47682-3_4

Practicalities of setting up a phase I clinical trial unit within an academic center

David S. Hong, Kathrina L. Marcelo-Lewis, Patricia LoRusso

Investigational Cancer Therapeutics

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Over 1100 cancer drugs are in development representing an increase in effort and progress in cancer drug discovery. The starting point of clinical development is Phase 1 clinical trials and the need for dedicated Phase I units have emerged as forefront necessity even in academic centers. Early phase oncology clinical trial units within an academic center allow for the conduct of clinical research at the highest standards combined with unique opportunities for intellectual development and research collaborations. We outline here some of the practical elements of a robust early drug development unit.

Original language	English (US)
Title of host publication	Phase I Oncology Drug Development
Publisher	Springer International Publishing
Pages	71-83
Number of pages	13
ISBN (Electronic)	9783030476823
ISBN (Print)	9783030476816
DOIs	https://doi.org/10.1007/978-3-030-47682-3_4
State	Published - Sep 16 2020

Keywords

Academic center
Drug development
Early phase oncology trials
Human research
Phase 1 unit

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-47682-3_4

Cite this

@inbook{81252a2b6308492dad07111718940d0e,

title = "Practicalities of setting up a phase I clinical trial unit within an academic center",

abstract = "Over 1100 cancer drugs are in development representing an increase in effort and progress in cancer drug discovery. The starting point of clinical development is Phase 1 clinical trials and the need for dedicated Phase I units have emerged as forefront necessity even in academic centers. Early phase oncology clinical trial units within an academic center allow for the conduct of clinical research at the highest standards combined with unique opportunities for intellectual development and research collaborations. We outline here some of the practical elements of a robust early drug development unit.",

keywords = "Academic center, Drug development, Early phase oncology trials, Human research, Phase 1 unit",

author = "Hong, {David S.} and Marcelo-Lewis, {Kathrina L.} and Patricia LoRusso",

year = "2020",

month = sep,

day = "16",

doi = "10.1007/978-3-030-47682-3_4",

language = "English (US)",

isbn = "9783030476816",

pages = "71--83",

booktitle = "Phase I Oncology Drug Development",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Practicalities of setting up a phase I clinical trial unit within an academic center

AU - Hong, David S.

AU - Marcelo-Lewis, Kathrina L.

AU - LoRusso, Patricia

PY - 2020/9/16

Y1 - 2020/9/16

N2 - Over 1100 cancer drugs are in development representing an increase in effort and progress in cancer drug discovery. The starting point of clinical development is Phase 1 clinical trials and the need for dedicated Phase I units have emerged as forefront necessity even in academic centers. Early phase oncology clinical trial units within an academic center allow for the conduct of clinical research at the highest standards combined with unique opportunities for intellectual development and research collaborations. We outline here some of the practical elements of a robust early drug development unit.

AB - Over 1100 cancer drugs are in development representing an increase in effort and progress in cancer drug discovery. The starting point of clinical development is Phase 1 clinical trials and the need for dedicated Phase I units have emerged as forefront necessity even in academic centers. Early phase oncology clinical trial units within an academic center allow for the conduct of clinical research at the highest standards combined with unique opportunities for intellectual development and research collaborations. We outline here some of the practical elements of a robust early drug development unit.

KW - Academic center

KW - Drug development

KW - Early phase oncology trials

KW - Human research

KW - Phase 1 unit

UR - http://www.scopus.com/inward/record.url?scp=85159172162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159172162&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-47682-3_4

DO - 10.1007/978-3-030-47682-3_4

M3 - Chapter

AN - SCOPUS:85159172162

SN - 9783030476816

SP - 71

EP - 83

BT - Phase I Oncology Drug Development

PB - Springer International Publishing

ER -

Practicalities of setting up a phase I clinical trial unit within an academic center

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this